| Literature DB >> 24088763 |
Masaki Yamamoto1, Saki Manabe, Yusuke Moriyama, Hiroshi Ishii, Shintetsu Tanaka, Ryohei Takahashi, Koji Tomaru, Nobuaki Kobayashi, Makoto Kudo, Masahiro Sasaki, Yoshiaki Inayama, Takeshi Kaneko, Yoshiaki Ishigatsubo.
Abstract
The prognosis is poor for patients with advanced pleomorphic carcinoma of the lung due to the generally limited response to chemotherapy and/or radiotherapy. It has been suggested the production of granulocyte colony-stimulating factor (G-CSF) by cancer cells may aggravate the disease progression. We herein report a case of a 73-year-old Japanese man with advanced G-CSF-producing pleomorphic carcinoma of the lung. First-line chemotherapy with carboplatin and paclitaxel had been suspended. Subsequent radiotherapy achieved a moderate volume reduction and an amelioration of the excessive G-CSF-related complications. Six cycles of second-line chemotherapy with docetaxel administered with good results. These combined treatments resulted in long term survival without progression of the disease.Entities:
Mesh:
Substances:
Year: 2012 PMID: 24088763 DOI: 10.2169/internalmedicine.52.0701
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271